Article: article from journal or magazin.
Case report (case report): feedback on an observation with a short commentary.
Occult HBV reactivation induced by ibrutinib treatment: a case report.
Acta Gastro-enterologica Belgica
Publication types: Case Reports ; Journal ArticlePublication Status: ppublish
Ibrutinib is a small molecule that has been recently developped for the treatment of B cell malignancies. Common side effects are diarrhoea, nausea, fatigue, infections, neutropenia and thrombocytopenia. Here we report the first case of Hepatitis B virus reactivation in a 80 years old chronic lymphocytic leukaemia patient receiving ibrutinib, suggesting that such treatment must be associated with HBV screening.
Aged, 80 and over, Hepatitis B/etiology, Hepatitis B/pathology, Humans, Leukemia, Lymphocytic, Chronic, B-Cell/complications, Leukemia, Lymphocytic, Chronic, B-Cell/drug therapy, Male, Pyrazoles/adverse effects, Pyrimidines/adverse effects, Virus Activation
Web of science
Last modification date